New nanomedicines for a more efficient and less aggressive treatment of prostate cancer

In Europe, prostate cancer is the most common type of cancer among men with an incidence greater than 100 cases per 100,000 individuals. Furthermore, it is currently the second most common cause of cancer-related deaths among men. This pathology mainly affects elderly men: nine in 10 deaths take place after 65 years of age. Therefore, it represents a very serious […]

Continue reading »

Researchers identify protein that contributes to racial disparities in prostate cancer

Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African-Americans than in Caucasian-Americans, but they’re only beginning to understand why. A Roswell Park Comprehensive Cancer Center study published today points to cellular factors that appear to be driving these disparities—mitochondrial differences that prevent formation of the cancer-killing […]

Continue reading »

Prostate cancer: Starving out the enemy

An old military tactic, widely used in Roman and medieval times, is now being put to good use in cancer research. The idea is that if you starve out your enemy—they will either submit or die. And in the race to develop treatments for prostate cancer, starving out those hostile cancer cells is proving effective. Metabolic biologist at the University […]

Continue reading »

Reliance on ‘YouTube medicine’ may be dangerous for those concerned about prostate cancer

The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and its Perlmutter Cancer Center, the study of the 150 most-viewed YouTube videos on the disease found that 77 percent had factual […]

Continue reading »

Hormone therapy can make prostate cancer worse, study finds

Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, killing […]

Continue reading »

Large US study targets prostate cancer in black men

(HealthDay)—Black men in the United States have higher rates of aggressive prostate cancer than other males. Now, a $26.5 million study is underway to figure out why. The U.S. National Institutes of Health and the Prostate Cancer Foundation have launched the study to investigate social, environmental and genetic factors behind this disparity. “No group in the world is hit harder […]

Continue reading »

The cause of prostate cancer progression to the incurable stage has likely been uncovered

Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism (SNP) rs11672691 influences prostate cancer aggressiveness. Their findings also suggest ways to improve risk stratification and clinical treatment for advanced prostate cancer. The study is published in the journal Cell. Three billion base pairs […]

Continue reading »

Scientists help identify genetic markers for prostate cancer in global DNA download

An international team of researchers including USC scientists has found scores of new genetic markers in DNA code that increase prostate cancer risk—powerful knowledge likely to prove useful to detect and prevent the disease. Focusing on DNA of more than 140,000 men worldwide, researchers were able to identify 63 new genetic markers associated with prostate cancer risk. That greatly increases […]

Continue reading »

Scientists screen molecules for promise as new prostate cancer drugs

Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs. The research team from the Departments of Pharmacy & Pharmacology and Chemistry are studying a protein called α-methylacyl-CoA racemase (AMACR) as a potential […]

Continue reading »

By 2030, prostate and lung cancers expected to be most common cancers among HIV population

Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers among individuals aging with HIV. The findings are published in Annals of Internal Medicine. Due to their weakened immune systems, people living with HIV have a […]

Continue reading »
1 2